In brief, we use multiple human tissue microarrays, spontaneous HCC mouse models, and current immune and molecular profiling tools to show that WSX1 downregulates neoplastic PD-L1 and reduces CD8+ T-cell exhaustion in the tumor microenvironment, leading to inhibition of oncogene-mediated HCC formation. This evidence concerns the gene CD8A and hepatocellular carcinoma.